#biopharma

[ follow ]
#ai-in-drug-discovery #clinical-trial-design #venture-funding #end-to-end-automation #seed-funding
Venture
fromfortune.com
1 day ago

Exclusive: Ex-Palantir AI execs raise $12 million seed round for Perceptic, a startup automating drug discovery

Perceptic is launching an end-to-end AI platform for drug discovery and clinical trial design, raising $12 million seed funding led by Accel.
fromTechCrunch
6 days ago

Imperagen raises 5 million to use quantum physics, AI on enzyme engineering | TechCrunch

Imperagen is using three core technologies as it seeks to redefine enzyme engineering. Specifically, it uses a quantum physics-based simulation instead of trial-and-error enzyme mutations in a lab. Imperagen predicts the behavior of enzyme variants on a computer using advanced quantum physics modeling that can explore millions of mutations, the company said. Then it translates this information into its custom AI models, trained on the enzyme problems Imperagen seeks to explore.
Venture
Growth hacking
fromEntrepreneur
3 weeks ago

Chicken or the Egg? Why We Need to Rethink Data and Funding in Startups

Biopharma companies must secure funding and generate compelling data to attract investors and ensure long-term growth.
Science
fromTechCrunch
1 month ago

AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter. | TechCrunch

AI's impact in science is exemplified by DeepMind's protein structure predictions, but characterizing treatment candidates remains a significant challenge.
Medicine
from24/7 Wall St.
1 month ago

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.
fromBoston.com
1 month ago

Major pharmaceutical company to cut nearly 250 Massachusetts jobs

The layoffs are part of a transformation plan approved by Takeda's board on March 25, expected to generate more than 200 billion Japanese yen in annualized savings by fiscal 2028, or about $1.25 billion.
Boston
Law
fromThe Verge
10 months ago

Errors found in US judge's withdrawn decision stink of AI

A U.S. district court judge withdrew his decision due to errors including fake quotes and incorrect case information.
[ Load more ]